C. Lino-de-oliveira et al., Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression, BRAIN RES B, 55(6), 2001, pp. 747-754
Chronic treatment with antidepressants has been shown to attenuate behavior
al changes induced by uncontrollable stress. The mechanisms and brain sites
of this effect, however, remain controversial. The objective of the presen
t work was to investigate the effects of chronic and acute treatment with f
luoxetine (FLX), a selective serotonin reuptake blocker, on Fos expression
in animals submitted to restraint stress. Male Wistar rats (n = 3-9/group)
received, during 1 or 21 days, intraperitoneal. Injections of vehicle (sali
ne + 0.2% Tween-80, 1 ml/kg) or FLX (10 mg/kg). One hour after the last inj
ection they were forced restrained for 2 h and sacrificed immediately after
. Non-stressed animals were sacrificed 2 h after the last injection. The br
ains were removed and processed for immunohistochemistry. Fos-like immunore
activity (FLI) was quantified by a computer system. In acutely treated anim
als FLX decreased stress-induced FLI in the medial amygdala (MeA), bed nucl
eus of the stria terminalis (BNST), ventrolateral part, and dorsolateral pe
riaqueductal gray (PAG). After chronic treatment, however, the drug induced
a significant increase in FLI in the BNST (ventrolateral and medial parts)
, lateral septal nucleus (LSN, dorsal part), dorsal raphe nucleus (DRN), an
d locus coeruleus in restrained group. In non-restrained animals chronic tr
eatment with FLX increased FLI in the MeA, BNST (ventrolateral and dorsolat
eral parts), LSN (dorsal and intermediate parts), dorsolateral and dorsomed
ial PAG and in the DRN. The results suggest that chronic fluoxetine treatme
nt induce plastic changes that result in a different regional pattern of Fo
s expression. (C) 2001 Elsevier Science Inc.